The investigation determined that lower than expected vitros tsh results were obtained from a single cap linearity sample ln5-14, tested on a vitros 5600 integrated system.A definitive assignable cause for the lower than expected vitros tsh cap linearity results could not be determined.Based on historical quality control results, a vitros tsh lot 5550 performance issue is not a likely contributor to the event.Follow up testing which included a dilution study with a patient sample with a tsh level >100miu/ml, and testing of vitros tsh range verifiers demonstrated vitros tsh lot 5550 is performing as expected.While a vitros tsh within-run precision test met performance guidelines, an instrument issue cannot be completely ruled out as several weeks had elapsed between the time of the event and the precision test.In addition, an interaction with the cap sample fluid matrix cannot be ruled out.A definitive assignable cause for the event could not be determined.
|
A customer obtained lower than expected vitros tsh results from a (b)(4) linearity sample tested on a vitros 5600 integrated system.Cap sample ln5-14 results of 43.1 and 43.2 miu/l vs.The expected result of 63.0312 miu/l biased results of the direction and magnitude observed may lead to inappropriate physician action.The lower than expected vitros tsh results were generated from non-patient fluid and the customer did not give any indication that patient results had been affected, however, the investigation could not rule out that patient samples were not, or would not be affected if the event were to recur undetected.There was no allegation of actual patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc.(b)(4).
|